Related Experiment Videos
[Changes in thyroid function in systemic lupus erythematosus, progressive systemic sclerosis and rheumatoid
Reumatizam
|January 1, 1994
Summary
Thyroid dysfunction is common in systemic connective tissue diseases like lupus, scleroderma, and rheumatoid arthritis. Regular thyroid monitoring is crucial for timely treatment in affected patients.
Area of Science:
- Rheumatology
- Endocrinology
- Immunology
Context:
- Systemic connective tissue diseases (SCTD) are frequently associated with endocrine abnormalities.
- Thyroid dysfunction can significantly impact patient prognosis and quality of life in SCTD.
- Understanding the prevalence of thyroid disorders in SCTD is essential for comprehensive patient care.
Purpose:
- To investigate the frequency of thyroid function disorders in patients with systemic erythematous lupus (SLE), progressive systemic sclerosis (PSS), and rheumatoid arthritis (RA).
- To assess the clinical significance of thyroid abnormalities in the context of these autoimmune diseases.
Summary:
- A cohort of 380 patients (70 SLE, 31 PSS, 270 RA) underwent thyroid function testing.
- Thyroid function disorders were detected in 21.43% of SLE patients, 35.48% of PSS patients, and 12.54% of RA patients.
- Hormone levels including thyroxine (T4), triiodothyronine (T3), and thyroid-stimulating hormone (TSH) were measured using validated immunoassay techniques.
Impact:
- The study highlights a significant prevalence of thyroid dysfunction in patients with SLE, PSS, and RA.
- Findings underscore the necessity for routine thyroid function monitoring in patients diagnosed with these connective tissue diseases.
- Early detection and management of thyroid disorders can lead to improved therapeutic outcomes and patient well-being.